Biopharmaceutical innovator.
Active 2024–2026.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2025 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2025 | FORBES-TATE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2025 | FORBES-TATE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2025 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2024 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2024 | FORBES-TATE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2024 | FORBES-TATE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2024 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | |
| 2024 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| FORBES-TATE | 10 | $380,000 |
| Issue | Activities |
|---|---|
| Health Issues | 9 |